Al-Moraissi Essam Ahmed, Altairi Nashwan Hamid, Abotaleb Bassam, Al-Iryani Ghassan, Halboub Essam, Alakhali Mohammed Sultan
Assistant Professor, Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Thamar University, Thamar, Yemen.
Assistant Professor, Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Thamar University, Thamar, Yemen.
J Oral Maxillofac Surg. 2019 Jan;77(1):70.e1-70.e33. doi: 10.1016/j.joms.2018.08.009. Epub 2018 Aug 22.
The most effective rehabilitation method for patients with edentulous posterior maxillas with an intermediate (4 to 8 mm) residual bone height (RBH) below the maxillary sinus is unclear. Evidence derived from conventional meta-analysis is limited because of the lack of head-to-head studies. This network meta-analysis (NMA) was performed to identify the most effective method to treat patients with intermediate posterior RBH.
An NMA of randomized controlled clinical trials (RCTs) was conducted to assess various rehabilitation methods using implant-supported prostheses for patients with intermediate posterior maxillary RBH (4 to 8 mm). Publications from 1970 through March 2018 in 3 major databases were searched. Parallel and split-mouth RCTs that reported the outcomes of interest with follow-up of at least 6 months from initial loading were included. Predictor variables were short implants (SIs; ≤8 mm) alone, SIs in conjunction with osteotome sinus floor elevation (OSFE) with or without bone grafting, long implants (LIs) in conjunction with OSFE with and without bone grafting, and LIs combined with lateral sinus floor elevation (LSFE) with bone grafting. Outcome variables were implant and prosthesis failure rates, marginal bone loss, and complications. Frequentist NMA was performed using STATA software.
Twenty RCTs involving 770 patients with intermediate posterior maxillary RBH and 837 concerned maxillary sinuses who received 1,486 implants using any of the 4 rehabilitation methods were included. There were no statistically significant differences among the 4 groups for implant and prosthesis failure rates and marginal bone loss at follow-up (range, 6 months to 5 years after loading). There was a marked decrease in complications for SIs alone compared with LIs combined with LSFE. For implant and prosthesis survival rates, SIs in conjunction with OSFE with or without bone grafting ranked first as the most effective option (77.1%) followed by LIs plus OSFE with or without bone grafting (62%), LIs plus LSFE with bone grafting (43.9%), and SIs alone (24.8%).
There is moderate-quality evidence derived from this NMA showing that OSFE combined with SI or LI placement with or without bone grafting or SI placement alone is superior to LI placement combined with LSFE and bone grafting when used for patients with intermediate maxillary RBH (4 to 8 mm). Furthermore, the results of this study show that LSFE for patients with intermediate RBH is not a suitable treatment option because of unjustified high cost and rate of complications.
上颌窦下方剩余骨高度(RBH)为中等(4至8毫米)的无牙后上颌患者最有效的康复方法尚不清楚。由于缺乏直接对比研究,传统荟萃分析得出的证据有限。进行这项网络荟萃分析(NMA)以确定治疗中等后牙RBH患者的最有效方法。
进行一项随机对照临床试验(RCT)的NMA,以评估使用种植体支持假体对上颌后牙中等RBH(4至8毫米)患者的各种康复方法。检索了1970年至2018年3月在3个主要数据库中的出版物。纳入了平行和分口RCT,这些研究报告了感兴趣的结果,且从初始加载起至少随访6个月。预测变量为单独使用短种植体(SI;≤8毫米)、SI联合骨凿上颌窦底提升(OSFE)(有或无骨移植)、长种植体(LI)联合OSFE(有或无骨移植)以及LI联合外侧上颌窦底提升(LSFE)并进行骨移植。结果变量为种植体和假体失败率、边缘骨丢失及并发症。使用STATA软件进行频率学派NMA。
纳入了20项RCT,涉及770例上颌后牙中等RBH患者和837例涉及上颌窦的患者,他们使用4种康复方法中的任何一种接受了1486颗种植体。随访时(加载后6个月至5年),4组在种植体和假体失败率以及边缘骨丢失方面无统计学显著差异。与LI联合LSFE相比,单独使用SI的并发症明显减少。对于种植体和假体生存率,SI联合OSFE(有或无骨移植)作为最有效的选择排名第一(77.1%),其次是LI加OSFE(有或无骨移植)(62%)、LI加LSFE并进行骨移植(43.9%)以及单独使用SI(24.8%)。
这项NMA得出中等质量的证据表明,当用于上颌中等RBH(4至8毫米)患者时,OSFE联合SI或LI植入(有或无骨移植)或单独植入SI优于LI植入联合LSFE和骨移植。此外,本研究结果表明,对于中等RBH患者,LSFE由于成本过高且并发症发生率不合理,不是一种合适的治疗选择。